A digital map featuring interconnected location pins, symbolizing global network connectivity and geographic information technology. Concept of global connections and geolocation maps for business.

Blood centers rely on blood collected at more than 800 donation sites across the country.

Each time a new donation site is opened, a blood center must go through an extensive licensure process to add the new site to their existing Blood License Application (BLA). This process can take more than a year, despite the blood center using the same Standard Operating Procedures (SOPs), devices, and staff as their primary licensed facility.

The Problem

  • Outdated regulations are creating significant bottlenecks in the U.S. blood supply chain.
  • Current rules require redundant reviews for new apheresis collection sites, despite prior FDA approval. This unnecessary duplication delays blood availability to patients and impedes blood centers' ability to adapt to changing needs.
  • As new donation locations open nationwide, these regulations pose a critical challenge. They not only slow down the process of establishing new collection sites but also create inefficiencies in an already complex healthcare system.

Take Action

Representatives Wied (R-WI-8) and Schrier (D-WA-8) introduced H.R. 5791, the Boosting Lifesaving Operations, Opening Donation (BLOOD) Centers Act. This bipartisan legislation would streamline the licensure process for blood centers by creating an expedited pathway to add new apheresis collection sites under an existing license. This marks a significant advancement on a key priority in our 2025 ABC Advocacy Agenda.

Urge your members of Congress to support this bill by sending prewritten messages - it takes only minutes but could have a lasting impact.

Make Your Voice Heard

Latest Developments

Blood Community Letter to FICEMS in Response to Request for Information on Nationwide Implementation of Prehospital Blood Transfusion

November 4, 2026
Posted in
November 12 / 1:37 am

America’s Blood Centers, AABB, and the American Red Cross submitted this comment letter to the National Highway Traffic Safety Administration (NHTSA), on behalf of the…

FDA Convenes Roundtable on Strengthening the Blood Manufacturing Supply Chain

November 3, 2026
Posted in
November 12 / 1:37 am

On September 29, the Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER) held a roundtable, “Strengthening the Supply Chain for Blood…

ABC Submits Comments to FDA Roundtable: Strengthening the Supply Chain for Blood Manufacturing

November 2, 2026
Posted in
November 12 / 1:37 am

America’s Blood Centers appreciates the opportunity to comment as part of this roundtable discussion. We also thank the FDA for convening industry, government, and blood…

Resources

Apheresis Collections Licensure Routes & Validation Data

Presentation by America's Blood Centers featuring flowcharts detailing the apheresis collections licensure routes and validation data.